• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多药耐药菌的抗真菌潜力:利用绿脓菌素抑制念珠菌生长。

Antifungal potential of multi-drug-resistant : harnessing pyocyanin for candida growth inhibition.

机构信息

Center of Excellence in Environmental Studies, King Abdulaziz University, Jeddah, Saudi Arabia.

Protein Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.

出版信息

Front Cell Infect Microbiol. 2024 May 22;14:1375872. doi: 10.3389/fcimb.2024.1375872. eCollection 2024.

DOI:10.3389/fcimb.2024.1375872
PMID:38846355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11155300/
Abstract

INTRODUCTION

is notorious for its multidrug resistance and its involvement in hospital-acquired infections. In this study, 20 bacterial strains isolated from soil samples near the Hindan River in Ghaziabad, India, were investigated for their biochemical and morphological characteristics, with a focus on identifying strains with exceptional drug resistance and pyocyanin production.

METHODS

The isolated bacterial strains were subjected to biochemical and morphological analyses to characterize their properties, with a particular emphasis on exopolysaccharide production. Strain GZB16/CEES1, exhibiting remarkable drug resistance and pyocyanin production. Biochemical and molecular analyses, including sequencing of its 16S rRNA gene (accession number LN735036.1), plasmid-curing assays, and estimation of plasmid size, were conducted to elucidate its drug resistance mechanisms and further pyocynin based target the Strain GZB16/CEES1 demonstrated 100% resistance to various antibiotics used in the investigation, with plasmid-curing assays, suggesting plasmid-based resistance gene transmission. The plasmid in GZB16/CEES1 was estimated to be approximately 24 kb in size. The study focused on 's pyocyanin production, revealing its association with anticandidal activity. The minimum inhibitory concentration (MIC) of the bacterial extract against was 50 μg/ml, with a slightly lower pyocyanin-based MIC of 38.5 μg/ml. Scanning electron microscopy illustrated direct interactions between strains and cells, leading to the destruction of the latter.

DISCUSSION

These findings underscore the potential of in understanding microbial interactions and developing strategies to combat fungal infections. The study highlights the importance of investigating bacterial-fungal interactions and the role of pyocyanin in antimicrobial activity. Further research in this area could lead to the development of novel therapeutic approaches for combating multidrug-resistant infections.

摘要

简介

因其多药耐药性及其在医院获得性感染中的作用而臭名昭著。在这项研究中,对从印度加济阿巴德欣丹河附近土壤样本中分离出的 20 株细菌菌株进行了生化和形态特征研究,重点是鉴定具有特殊耐药性和绿脓菌素产生的菌株。

方法

对分离出的细菌菌株进行生化和形态分析,以表征其特性,特别强调胞外多糖的产生。菌株 GZB16/CEES1 表现出显著的耐药性和绿脓菌素产生。进行了生化和分子分析,包括其 16S rRNA 基因(登录号 LN735036.1)的测序、质粒消除试验和质粒大小估计,以阐明其耐药机制,并进一步针对绿脓菌素的靶标。GZB16/CEES1 对研究中使用的各种抗生素表现出 100%的耐药性,通过质粒消除试验,提示存在基于质粒的耐药基因传递。GZB16/CEES1 中的质粒估计大小约为 24kb。该研究重点关注 的绿脓菌素产生,揭示其与抗真菌活性的关联。细菌提取物对 的最小抑菌浓度(MIC)为 50μg/ml,基于绿脓菌素的 MIC 略低,为 38.5μg/ml。扫描电子显微镜显示了 菌株与 细胞之间的直接相互作用,导致后者被破坏。

讨论

这些发现强调了 在理解微生物相互作用和开发抗真菌感染策略方面的潜力。该研究强调了研究细菌-真菌相互作用和绿脓菌素在抗菌活性中的作用的重要性。该领域的进一步研究可能导致开发针对多药耐药感染的新型治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/9b5eb5d6c4f9/fcimb-14-1375872-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/f67b1ce80117/fcimb-14-1375872-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/56bb37f7c523/fcimb-14-1375872-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/b4dad9d87b3c/fcimb-14-1375872-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/7ba9f7be27cf/fcimb-14-1375872-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/833668da2bca/fcimb-14-1375872-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/6f23c633a230/fcimb-14-1375872-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/64076e6f72d0/fcimb-14-1375872-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/e075f501e826/fcimb-14-1375872-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/9b5eb5d6c4f9/fcimb-14-1375872-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/f67b1ce80117/fcimb-14-1375872-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/56bb37f7c523/fcimb-14-1375872-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/b4dad9d87b3c/fcimb-14-1375872-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/7ba9f7be27cf/fcimb-14-1375872-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/833668da2bca/fcimb-14-1375872-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/6f23c633a230/fcimb-14-1375872-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/64076e6f72d0/fcimb-14-1375872-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/e075f501e826/fcimb-14-1375872-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8390/11155300/9b5eb5d6c4f9/fcimb-14-1375872-g009.jpg

相似文献

1
Antifungal potential of multi-drug-resistant : harnessing pyocyanin for candida growth inhibition.多药耐药菌的抗真菌潜力:利用绿脓菌素抑制念珠菌生长。
Front Cell Infect Microbiol. 2024 May 22;14:1375872. doi: 10.3389/fcimb.2024.1375872. eCollection 2024.
2
Pharmacological validation of Solanum mammosum L. as an anti-infective agent: Role of solamargine.索拉玛戈因在防治感染方面的药理学验证:以茄属植物为研究对象。
J Ethnopharmacol. 2021 Nov 15;280:114473. doi: 10.1016/j.jep.2021.114473. Epub 2021 Jul 31.
3
Reduction of virulence factor pyocyanin production in multidrug-resistant Pseudomonas aeruginosa.降低多重耐药铜绿假单胞菌毒力因子绿脓菌素的产生。
J Infect Chemother. 2013 Feb;19(1):82-8. doi: 10.1007/s10156-012-0457-9. Epub 2012 Aug 3.
4
Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth.铜绿假单胞菌绿脓菌素和1-羟基吩嗪可抑制真菌生长。
J Clin Pathol. 1999 May;52(5):385-7. doi: 10.1136/jcp.52.5.385.
5
Under nonlimiting iron conditions pyocyanin is a major antifungal molecule, and differences between prototypic Pseudomonas aeruginosa strains.在非铁限制条件下,绿脓菌素是一种主要的抗真菌分子,也是典型铜绿假单胞菌菌株之间的差异所在。
Med Mycol. 2021 May 4;59(5):453-464. doi: 10.1093/mmy/myaa066.
6
Multidrug-resistant Pseudomonas aeruginosa strains harbouring R-plasmids and AmpC beta-lactamases isolated from hospitalised burn patients in a tertiary care hospital of North India.从印度北部一家三级护理医院的住院烧伤患者中分离出的携带R质粒和AmpCβ-内酰胺酶的多重耐药铜绿假单胞菌菌株。
FEMS Microbiol Lett. 2003 Nov 21;228(2):181-6. doi: 10.1016/S0378-1097(03)00756-0.
7
Genome analyses of colistin-resistant high-risk bla producing Klebsiella pneumoniae ST147 and Pseudomonas aeruginosa ST235 and ST357 in clinical settings.临床环境中产高风险 bla 碳青霉烯酶的耐药肺炎克雷伯菌 ST147 和铜绿假单胞菌 ST235 和 ST357 的基因组分析。
BMC Microbiol. 2024 May 20;24(1):174. doi: 10.1186/s12866-024-03306-4.
8
Characterization of a Conjugative Multidrug Resistance IncP-2 Megaplasmid, pPAG5, from a Clinical Pseudomonas aeruginosa Isolate.临床分离铜绿假单胞菌中接合型多药耐药 IncP-2 型大质粒 pPAG5 的特性。
Microbiol Spectr. 2022 Feb 23;10(1):e0199221. doi: 10.1128/spectrum.01992-21. Epub 2022 Feb 16.
9
Tracking of Antibiotic Resistance Transfer and Rapid Plasmid Evolution in a Hospital Setting by Nanopore Sequencing.通过纳米孔测序追踪医院环境中的抗生素耐药性转移和快速质粒进化。
mSphere. 2020 Aug 19;5(4):e00525-20. doi: 10.1128/mSphere.00525-20.
10
Transforming microbial pigment into therapeutic revelation: extraction and characterization of pyocyanin from Pseudomonas aeruginosa and its therapeutic potential as an antibacterial and anticancer agent.将微生物色素转化为治疗新发现:从铜绿假单胞菌中提取和鉴定绿脓菌素及其作为抗菌和抗癌剂的治疗潜力。
Microb Cell Fact. 2024 Jun 13;23(1):174. doi: 10.1186/s12934-024-02438-6.

引用本文的文献

1
An insight into pyocyanin: production, characterization, and evaluation of its in vitro antibacterial, antifungal, antibiofilm and in vivo anti-schistosomal potency.对绿脓菌素的深入研究:其产生、特性及其体外抗菌、抗真菌、抗生物膜活性以及体内抗血吸虫效力的评估
BMC Microbiol. 2025 Aug 23;25(1):532. doi: 10.1186/s12866-025-04248-1.

本文引用的文献

1
Burden of infectious diseases and bacterial antimicrobial resistance in China: a systematic analysis for the global burden of disease study 2019.中国传染病负担与细菌耐药性:2019年全球疾病负担研究的系统分析
Lancet Reg Health West Pac. 2023 Nov 22;43:100972. doi: 10.1016/j.lanwpc.2023.100972. eCollection 2024 Feb.
2
Therapeutic Strategies against Biofilm Infections.针对生物膜感染的治疗策略。
Life (Basel). 2023 Jan 6;13(1):172. doi: 10.3390/life13010172.
3
: Infections, Animal Modeling, and Therapeutics.感染、动物模型与治疗学
Cells. 2023 Jan 3;12(1):199. doi: 10.3390/cells12010199.
4
Emergent crisis of antibiotic resistance: A silent pandemic threat to 21 century.抗生素耐药性的紧急危机:21 世纪无声的大流行病威胁。
Microb Pathog. 2023 Jan;174:105923. doi: 10.1016/j.micpath.2022.105923. Epub 2022 Dec 13.
5
Secondary Metabolites Produced during Aspergillus fumigatus and Pseudomonas aeruginosa Biofilm Formation.烟曲霉和铜绿假单胞菌生物膜形成过程中产生的次生代谢产物。
mBio. 2022 Aug 30;13(4):e0185022. doi: 10.1128/mbio.01850-22. Epub 2022 Jul 20.
6
Prevalence of ESKAPE pathogens in the environment: Antibiotic resistance status, community-acquired infection and risk to human health.环境中 ESKAPE 病原体的流行情况:抗生素耐药性状况、社区获得性感染和对人类健康的威胁。
Int J Hyg Environ Health. 2022 Jul;244:114006. doi: 10.1016/j.ijheh.2022.114006. Epub 2022 Jul 13.
7
Infections in Cancer Patients.癌症患者的感染
Pathogens. 2022 Jun 12;11(6):679. doi: 10.3390/pathogens11060679.
8
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects.微生物的抗生素耐药性:历史、机制、治疗策略和未来前景。
J Infect Public Health. 2021 Dec;14(12):1750-1766. doi: 10.1016/j.jiph.2021.10.020. Epub 2021 Oct 23.
9
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update.铜绿假单胞菌感染的流行病学、发病机制和治疗:最新进展。
Drugs. 2021 Dec;81(18):2117-2131. doi: 10.1007/s40265-021-01635-6. Epub 2021 Nov 7.
10
Comparison of 16S rRNA Gene Based Microbial Profiling Using Five Next-Generation Sequencers and Various Primers.使用五种下一代测序仪和各种引物基于16S rRNA基因的微生物谱分析比较
Front Microbiol. 2021 Oct 14;12:715500. doi: 10.3389/fmicb.2021.715500. eCollection 2021.